Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Hasselt University
With
Jessa Hospital
Ziekenhuis Oost-Limburg
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Informed Consent as documented by signature
Diagnosis of non-invasive (stage 0) or invasive (stage 1, 2 and 3A) breast adenocarcinoma
Treatment with primary breast-sparing surgery (lumpectomy) and/or neoadjuvant (preoperative) or adjuvant (postoperative) chemotherapy or hormonal therapy
Scheduled for postoperative radiotherapy at Ziekenhuis Oost-Limburg, Genk:
Hypofractionated radiotherapy regimen (i.e. 16 daily fractions of 2.66 Gray to the whole breast followed by a boost of 5 fractions of 2.66 Gray to the tumor bed, 5x/week)
You may not be if
Scheduled for postoperative radiotherapy at Jessa Hospital, Hasselt, Belgium
Previous irradiation to the same breast
Metastatic disease
Concurrent chemotherapy
Required use of bolus material to deliver radiotherapy (i.e material placed on the to-be- irradiated zone to modulate the delivered dose in order to ensure an optimal distribution of the radiation dose; mostly used for treatment of superficial tumors)
Known or suspected non-compliance, drug or alcohol abuse
Inability to follow the procedures of the study, e.g. due to language problems, psyschological disorders, dementia, etc. of the participant
Seizure
Disorders triggered by lighttake anticoagulants
Hemorrhagic diatheses
Pregnancy
Suspected of carrying serious infectious disease
HIV positive history
Clareo Health | Photobiomodulation Therapy for the Prevention of Acute Radiodermatitis in Breast Cancer Patients Undergoing Radiotherapy
